CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AE0. A total of 8 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,105,000,000 | -8.8% | 8,500,000 | +3.0% | 0.10% | +18.3% |
| Q2 2022 | $5,595,000,000 | +63.4% | 8,250,000 | +83.3% | 0.08% | +148.5% |
| Q4 2021 | $3,424,000,000 | -4.9% | 4,500,000 | +12.5% | 0.03% | +17.9% |
| Q3 2021 | $3,600,000,000 | -14.4% | 4,000,000 | 0.0% | 0.03% | -26.3% |
| Q2 2021 | $4,207,000,000 | -5.5% | 4,000,000 | 0.0% | 0.04% | -40.6% |
| Q1 2021 | $4,453,000,000 | +30.3% | 4,000,000 | 0.0% | 0.06% | -8.6% |
| Q4 2020 | $3,417,000,000 | – | 4,000,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 21,000,000 | $12,750,000 | 0.89% |
| LMR Partners LLP | 13,099,000 | $9,612,000 | 0.18% |
| ARISTEIA CAPITAL, L.L.C. | 15,150,000 | $8,844,000 | 0.15% |
| UBS OCONNOR LLC | 8,500,000 | $5,105,000,000 | 0.10% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,100,000 | $4,145,000 | 0.02% |
| WELLS FARGO & COMPANY/MN | 2,025,000 | $1,146,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |